rs1555371769
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_001355436.2(SPTB):c.647G>A(p.Arg216Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001355436.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTB | NM_001355436.2 | c.647G>A | p.Arg216Gln | missense_variant, splice_region_variant | 6/36 | ENST00000644917.1 | NP_001342365.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTB | ENST00000644917.1 | c.647G>A | p.Arg216Gln | missense_variant, splice_region_variant | 6/36 | NM_001355436.2 | ENSP00000495909.1 | |||
SPTB | ENST00000389722.7 | c.647G>A | p.Arg216Gln | missense_variant, splice_region_variant | 5/35 | 2 | ENSP00000374372.3 | |||
SPTB | ENST00000389720.4 | c.647G>A | p.Arg216Gln | missense_variant, splice_region_variant | 6/32 | 5 | ENSP00000374370.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461736Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727176
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 28, 2024 | PP1_strong, PP3, PP5, PM2_moderate, PS4_moderate - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 14, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 544811). This missense change has been observed in individual(s) with SPTB related conditions (PMID: 29572776, 33074480). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 216 of the SPTB protein (p.Arg216Gln). This variant also falls at the last nucleotide of exon 5, which is part of the consensus splice site for this exon. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 15, 2023 | - - |
Elliptocytosis 3;C2674219:Hereditary spherocytosis type 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PP3_Moderate+PS4_Supporting+PP4+PP1_Strong - |
SPTB-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 07, 2023 | The SPTB c.647G>A variant is predicted to result in the amino acid substitution p.Arg216Gln. This variant was reported in an individual with jaundice and a patient with hereditary spherocytosis (Wang et al 2018. PubMed ID: 29572776; Vives-Corrons JL et al 2020. PubMed ID: 33074480). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. The c.647G>A variant also resides at the exon/intron boundary and is predicted to weaken the splice donor site based on available splicing prediction programs (Alamut v.2.11). We have observed the c.647G>A variant at PreventionGenetics in other patients with hereditary spherocytosis. This variant is interpreted as likely pathogenic. - |
Hereditary spherocytosis type 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Department of Genetic, Henri Mondor Hospital, Assistance Publique des Hôpitaux de Paris | Feb 27, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at